Summit Therapeutics (SMMT) - 2024 Q1 - Quarterly Results

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024 Miami, Florida, May 1, 2024 - Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on its operational progress for the first quarter ended March 31, 2024. Operational & Corporate Updates • Our operational progress continues with ivonescimab (SMT112), an investigational, potentially first-in-class bispecific antibody ...